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Abstract
Background: Stuttering is a complex speech disorder that affects speech fluency. Recently, it has been shown that noninvasive
brain stimulation may be useful to enhance the results of fluency interventions in adults who stutter. Delayed auditory feedback
(DAF) is a method to enhance speech fluency in individuals who stutter. Adjunctive interventions are warranted to enhance the
efficacy of this intervention.
Objective: Individuals who stutter have pathological activation patterns in the primary and secondary auditory areas. Consequently,
in this study, we hypothesize that stimulation of these areas might be promising as an adjunctive method to fluency training via
DAF to enhance speech therapy success in individuals with a stutter. We will systematically test this hypothesis in this study.
Methods: This study is designed as a randomized, double-blind, sham-controlled clinical trial. All participants will receive
DAF. The intervention group will additionally receive real transcranial direct current stimulation, while the control group will
be exposed to sham stimulation. The assignment of the participants to one of these groups will be randomized. Before starting
the treatment program, 2 preintervention assessments will be conducted to determine the severity of stuttering. Once these
assessments are completed, each subject will participate in 6 intervention sessions. Postintervention assessments will be carried
out immediately and 1 week after the last intervention session. Subsequently, to explore the long-term stability of the treatment
results, the outcome parameters will be obtained in follow-up assessments 6 weeks after the treatment. The primary outcome
measurement—the percentage of stuttered syllables—will be calculated in pre-, post-, and follow-up assessments; the secondary
outcomes will be the scores of the following questionnaires: the Stuttering Severity Instrument–Fourth Edition and the Overall
Assessment of the Speaker’s Experience of Stuttering.
Results: This protocol was funded in 2019 and approved by the Research Ethics Committee of the Iran University of Medical
Sciences in June 2019. Data collection started in October 2019. As of February 2020, we have enrolled 30 participants. We expect
data analysis to be completed in April 2020, and results will be published in summer 2020.
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Conclusions: We anticipate that this study will show an adjunctive effect of transcranial direct current stimulation, when
combined with DAF, on stuttering. This should include not only a reduction in the percentage of stuttered syllables but also
improved physical behavior and quality of life in adults who stutter.
Trial Registration: ClinicalTrial.gov NCT03990168; https://clinicaltrials.gov/ct2/show/NCT03990168
International Registered Report Identifier (IRRID): DERR1-10.2196/16646
(JMIR Res Protoc 2020;9(4):e16646) doi: 10.2196/16646
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Introduction
Stuttering is a complex speech disorder that affects speech
fluency, as defined by repetitions, prolongations, and blocks in
speech sound [1]. It is prevalent in 1% of the population [2].
Despite advances in the treatment of stuttering, major limitations
such as instability of treatment outcomes and lack of long-term
results have yet to be addressed [3]. Recently, it has been shown
that noninvasive brain stimulation may be useful to enhance
the results of fluency interventions in adults who stutter [4].
One of these tools is transcranial direct current stimulation
(tDCS), a noninvasive brain stimulation technique that uses a
weak, constant current of 1-2 mA that passes through the scalp
and results in alterations in cortical excitability and activity [5].
Structural and functional neuroimaging in individuals who
stutter show bilateral underactivation of the primary and
secondary auditory areas as compared to adults who do not
stutter [6]. Delayed auditory feedback (DAF) is a method to
enhance speech fluency in individuals who stutter. In this
method, alteration of the timing feedback affects speech rate
and consequently results in increased fluency [7]. A recent study
has shown that in individuals who undergo DAF, enhanced
speech fluency is associated with increased activity in the
primary and secondary auditory areas of the superior temporal
gyrus [8]. DAF is, however, time-consuming, and long-term
reductions in stuttering are still restricted [9]. Adjunctive
interventions are thus warranted to enhance the efficacy of this
intervention. Thus, to increase speech fluency, we will combine
DAF as a speech fluency intervention with tDCS applied over
the superior temporal gyrus (electrode position T3 of the 10-20
international system) to enhance efficacy of the fluency
intervention. Given past evidence that tDCS is capable of
inducing plasticity-like changes in cortical functions that can
outlast the stimulation period, we anticipate that tDCS will help
stabilize intervention-related improvements in speech fluency
[10].
In tDCS, electrical current flows between 2 or more
electrodes—a positively charged anode and a negatively charged
cathode—which are positioned at specified locations on the
scalp. The current produced by tDCS results in subtle changes
in the resting membrane potential of cortical neurons in the
underlying brain tissue [5]. Specifically, with standard protocols,
changes under the anode (referred to as anodal stimulation)
result in the depolarization of critical neuronal compartments,
thus increasing neuronal excitability, while changes under the
cathode (cathodal stimulation) result in the hyperpolarization
of respective compartments and decrease excitability at the
macroscopic level [11]. Neuroplastic effects emerge after some
minutes of stimulation, depending on alterations to glutamatergic
and GABAergic activities [12,13]. Similar to the acute
membrane polarization effects, anodal tDCS and cathodal tDCS
result in excitability-enhancing and excitability-reducing
plasticity, respectively [10,14,15].
In recent years, studies have shown that tDCS enhances speech
fluency in adults who stutter when applied during a fluency
intervention [4,16]. Since, in addition to the temporal auditory
areas, the frontal cortex shows abnormalities during stuttering,
tDCS was applied over the latter area in a recent study [4].
Chesters et al [4] investigated the effect of 5 sessions of anodal
tDCS over the left inferior frontal gyrus during a speech fluency
intervention on stuttering. Speech fluency significantly improved
in the treatment group that received anodal tDCS combined
with the fluency intervention in comparison with the respective
sham tDCS group. It was concluded that using tDCS
simultaneously with fluency training can enhance speech fluency
in adults who stutter.
Due to impaired sensory-motor integration, stutterers have
pathological activation patterns in the temporal lobe (ie, the
primary and secondary auditory areas are underactive while
speaking) [6]. Consequently, in this study, we hypothesize that
stimulation of these areas might be promising as an adjunctive
method to fluency training via DAF, to enhance speech therapy
success in individuals with a stutter. We will systematically test
this hypothesis in this study.
Methods
Overview
This project aims to investigate the effect of adjunctive
noninvasive brain stimulation on speech fluency. To this aim,
we will recruit 2 groups of participants—an intervention group
and a control group. In the intervention group, participants will
receive anodal tDCS simultaneously with DAF as a fluency
intervention, whereas the participants in the control group will
receive sham stimulation during DAF. The population of this
study will be adults with a stutter. We hypothesize that anodal
tDCS over the temporal target area will improve the efficacy
of DAF to enhance speech fluency and will stabilize treatment
effects.
Hypothesis
We hypothesize that the efficacy of the intervention to enhance
fluency of speech in individuals with a stutter is improved when
JMIR Res Protoc 2020 | vol. 9 | iss. 4 | e16646 | p. 2http://www.researchprotocols.org/2020/4/e16646/
(page number not for citation purposes)
Moein et alJMIR RESEARCH PROTOCOLS
XSL•FO
RenderX
combined with anodal tDCS over the superior temporal gyrus,
as compared to a sham tDCS control condition.
Primary Objectives
The primary objective of this proposal is to compare the mean
score of the percentage of stuttered syllables (SS%) [17] between
the intervention and control groups at 5 time points: 1 week
before treatment; immediately before treatment; and
immediately, 1 week, and 6 weeks after treatment.
Secondary Objectives
The secondary objectives are as follows:
• Comparison of the mean score of stuttered syllables,
duration, physical concomitant behaviors, and total score
of the Stuttering Severity Instrument-Fourth Edition (SSI-4)
questionnaire [18] between the intervention and control
groups 1 week before treatment; immediately before
treatment; and immediately, 1 week, and 6 weeks after
treatment.
• Comparison of the means of the general information section,
reaction to stuttering section, communication in daily
situations section, quality of life section, total impact score,
and impact rating of the Overall Assessment of the
Speaker’s Experience of Stuttering (OASES) questionnaire
[19] between the intervention and control groups 1 week
before treatment; immediately before treatment; and
immediately, 1 week, and 6 weeks after treatment.
Efficacy
We expect adjunctive tDCS to enhance the magnitude of the
effects of the intervention on our outcome parameters and to
enhance the stability of improvements made due to the
treatment.
Safety
There is no anticipated relevant risk associated with the
stimulation parameters used in this study [20]. In a systematic
review evaluating adverse effects of all published tDCS studies,
including studies conducted in vulnerable populations, adverse
effects of tDCS such as tingling and itching sensations under
the electrodes were mild and disappeared soon after stimulation.
No severe adverse effects of tDCS have been documented so
far. It thus can be concluded that tDCS within the proposed
stimulation parameters is safe [21].
Study Population
The study population will include adults with moderate-to-severe
stuttering who have not received any treatment at least 1 month
prior to the intervention. A speech-language pathologist will
assess the severity of stuttering in each subject to determine
whether he or she can be enrolled. The SSI-4 questionnaire will
be used to assess stuttering severity. Inclusion, exclusion, and
withdrawal criteria are listed in Textbox 1.
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Textbox 1. Inclusion, exclusion, and withdrawal criteria.
Inclusion criteria:
• History of developmental stuttering
• Participants diagnosed with moderate-to-severe stuttering
• Right-handed
• 18 to 50 years of age (adult)
• Native speaker of Farsi
• Nonsmoker
Exclusion criteria:
• Stuttering accompanied by other speech or language disorders
• Stuttering treatment within 1 month prior to the intervention
• Hearing loss
• History of neurological or psychiatric disorders
• History of seizures
• Intake of any medication that affects brain functions (eg, antidepressants)
• Pregnancy
• Breastfeeding
• Cranial bone defects
• Cranial or brain metal implants
• Skin lesions
Withdrawal criteria:
• Request to withdraw from the study at any point during the treatment program
• Skin damage or major adverse effects of stimulation
Study Design
This study is designed as a randomized, double-blind,
sham-controlled clinical trial. Participants will be randomly
allocated to a control or intervention group. All participants will
receive DAF during the intervention. The intervention group
will additionally receive anodal tDCS, while the control group
is exposed to sham tDCS. Data will be collected via
questionnaires, voice recordings, and observations at 5 time
points (ie, 1 week and immediately before the intervention; and
immediately, 1 week, and 6 weeks post intervention). By
comparing the outcomes of the respective treatments, we will
investigate the efficacy of anodal tDCS combined with DAF in
enhancing speech fluency.
Before starting the treatment program, 2 preintervention
assessments will be conducted to determine the severity of
stuttering. Once these assessments are completed, each subject
will participate in 6 intervention sessions. Postintervention
assessments will be carried out immediately and 1 week after
the last intervention session. Afterward, to explore the long-term
stability of the treatment results, the outcome parameters will
be obtained in follow-up assessments 6 weeks after the
treatment. This single-center trial will be conducted at the
Vahdat Neurorehabilitation Clinic in Tehran, Iran.
As previously mentioned, the study will be conducted on adults
with moderate-to-severe stuttering; hence, prior to recruitment,
the severity of stuttering will be assessed to determine
enrollment eligibility. In order to determine the severity of
stuttering, an SSI-4 score for each individual will be calculated.
We will obtain two baseline measurements—one at 1 week and
the other immediately before the intervention—to guarantee
symptom stability. At baseline, the participants will be visited
individually, and their voices will be recorded while performing
3 different tasks (ie, oral reading, monologue, and conversation).
Based on these data, we will calculate the primary outcome
measure (ie, SS%). The voice of the participants will be recorded
by a H5 Handy Recorder ZOOM). Two experienced specialist
raters will independently count the SS% of all speech samples.
In order to determine interrater reliability, Cohen kappa will be
calculated. In cases of agreement between the raters (intraclass
correlation coefficient=0.8-1), the SS% will be reported. In
cases of disagreement (intraclass correlation coefficient <0.8),
a third senior rater will evaluate SS%.
During the two baseline sessions, the principal investigator will
observe physical behavior, which is required to calculate the
SSI-4 score. The final part of the preintervention assessments
is the completion of the OASES questionnaire by the
participants. After the second baseline assessment, the
intervention will start and carry on for 6 consecutive days.
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At 3 time points after the last intervention session (ie,
immediately, 1 week, and 6 weeks), each subject will undergo
postintervention assessments, which will be identical to the
preintervention assessments and obtained by the same raters.
The trial design and timeline are shown in Figure 1.
After each intervention session, participants will fill out a
questionnaire using a 5-point Likert scale (1=very mild, 5=very
severe) to report potential side effects of tDCS, including
itching, burning, tingling, headache, fatigue, sudden mood
change, difficulties in concentration, changes in visual
perception, unpleasant somatosensory sensations, unpleasant
visual sensations, nausea, drowsiness, persisting feelings of
stimulation, and 1 open question for any other adverse effects.
In addition, to ensure successful blinding, participants will be
asked to guess the type of treatment they will or had received
(ie, anodal tDCS or sham) before and after the intervention.
Figure 1. Trial design and timeline. DAF: Delayed Auditory Feedback; OASES: Overall Assessment of the Speaker’s Experience of Stuttering; SS%:
percentage of stuttered syllables; SSI-4: Stuttering Severity Instrument-Fourth Edition; tDCS: transcranial direct current stimulation.
Randomization and Blinding
This study is a randomized, double-blind, sham-controlled trial.
Participants will be randomly allocated to the intervention and
control groups. The random assignment of participants ensures
the prevention of a possible selection bias and a disbalance of
confounding factors between the study arms. Randomization
will be performed via a web-based randomization tool [22]. In
accordance with the requirements of this tool, we will include
50 subjects and 4 blocks of equal size, for which randomization
will be performed independently. Each subject will be given an
ID number and will be assigned to one of the treatment groups.
The individual responsible for generating the random list will
not be involved in any other part of the trial.
As the study is double-blinded, neither the participants nor the
investigators will know which group each participant will be
assigned to. Sealed opaque envelopes will be used for
concealment. Accordingly, an envelope will be produced for
each subject. These envelopes will be marked with an ID
number, and the treatment group associated with each ID will
be placed in its respective envelope. In order to guarantee double
blinding, specific letters, unknown to the principal investigator
and the subjects, will be used instead of the actual names of the
treatment groups (ie, intervention and control) inside the
envelopes. Assignment of these letters to the respective
intervention group will be done by a clinician (not the principal
investigator). Before the principal investigator starts the
treatment of the respective participant, the subject will be given
one of the sealed envelopes by the clinician. Once the envelope
is opened by the corresponding participant, the clinician will
set up the mode—anodal or sham—based on the content of the
subject's envelope and attach the electrodes to the participant´s
head as illustrated in the sections below. Once completed, the
principal investigator will commence the treatment. The
researchers who are responsible for outcome assessment and
data analysis will also be blinded to the intervention groups.
Intervention Program
Performance of Transcranial Current Direct Stimulation
The stimulation will be done by passing a current of 1 mA
between two 5 cm × 7 cm electrodes for a duration of 20 minutes
with ramp-up and ramp-down intervals of 15 seconds. This
common setup has been shown to be efficient for enhancing
speech fluency in previous tDCS studies [3,4]. A neuroConn
DC-STIMULATOR will be used to deliver tDCS. The electrodes
used for tDCS are conductive rubber electrodes encased in a
sponge pocket, and saline solution will be used as an
electrolyte-based contact medium. The electrode sponges must
be saturated with saline. It is crucial that each side of the sponges
is sufficiently moisturized, but not overly saturated, to avoid
dripping. Before placing electrodes on the scalp, the clinician
will inspect the skin for any skin damage or lesion. For both
anodal and sham modes, the same stimulation intensity
parameters will be used. However, for the sham stimulation,
the device will ramp down automatically after 30 seconds. The
intervention will be conducted for 6 consecutive days.
An electroencephalogram cap will be used to identify the site
of stimulation. The anode electrode will be placed over the left
superior temporal gyrus (T3 according to the 10-20 international
system [23]), and the cathode electrode will be positioned over
the right frontopolar region (Fp2 according to the 10-20 system
[23]). To prevent movement of the electrodes, their positions
will be fixed by elastic rubber straps. Electrode placement is
shown in Figure 2.
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Figure 2. Electrode placement.
Performance of Delayed Auditory Feedback
During stimulation, participants of both groups will receive
DAF as a fluency treatment. In order to deliver DAF, Audapter,
which is a software package for manipulating the acoustic
parameters of speech in real time, will be used [24]. This
package consists of the core algorithm for real-time
manipulation and a MATLAB wrap-around. The real-time signal
processing algorithms are coded in C++. The subjects will
perform 3 tasks (ie, oral reading, monologue, and conversation)
with DAF <60 ms. This 60-ms delay has been shown to be
efficient to enhance speech fluency in individuals with a stutter
[25].
Although, as outlined above, we do not anticipate major adverse
events, the occurrence of skin irritations, itching, tingling,
burning, or pain (including headache) will be monitored. After
each intervention session, a side effects questionnaire will be
filled out by participants. Furthermore, participants will guess
if they received anodal or sham stimulation before the
intervention, after the first session, and after the intervention
period to ensure successful blinding.
Data from the respective questionnaires will be recorded on
paper, and recordings of subjects’ voices will be stored
electronically. Access to data resources will be restricted to the
investigators. Finally, all study documents will be securely
maintained for 2 years.
Statistical and Analytical Analyses
In this proposal, the null hypothesis (H0) is that the combined
treatment method using tDCS stimulation and DAF, as compared
to DAF combined with sham stimulation, has no additional
effect on the enhancement of speech fluency in adults who
stutter.
Intended Sample Size
Based on the previous study by Chester et al [4], and using
G*Power software [26], 25 subjects per group (50 participants
in total) are required to detect a significant difference for a time
× group interaction using a two-way mixed model analysis of
variance (ANOVA). Time is the within-subject factor (ie, before
the intervention and immediately, 1 week, and 6 weeks after
the intervention), and group is the between-subject factor (ie,
anodal or sham tDCS). The dependent variable is stuttered
syllables (SS%). Type I (α) and type II (β) errors are set at .05
and .20, respectively, and the effect size is 0.17.
Other Statistical Analyses
Descriptive statistics will be calculated for demographic and
baseline characteristics as well as primary and secondary
outcomes for all participants. For every subject, summary
statistics including mean, SD, median, minimum, and maximum
will be provided for quantitative variables. For qualitative
variables, frequency tables will be presented. Group differences
of demographic variables will be assessed by Student t tests for
quantitative variables and chi-square tests for qualitative
variables.
In order to evaluate the effect of the treatment, the early and
late outcomes (ie, measurements taken immediately, 1 week
after treatment, and 6 weeks after treatment) will be examined.
Depending on the significance of the ANOVA results,
exploratory post hoc Student t tests will be conducted to
compare conditions. The same procedures will be conducted
for the secondary outcome parameters.
Data on tolerability and safety will be analyzed using an
independent samples t test for common adverse events. Reports
of rare side effects will be documented. To confirm successful
blinding, a chi-square test will be applied.
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Participants may be lost to follow-up for two reasons: (1) they
have not completed at least 80% of the treatment (5 out of 6
sessions) and (2) they did not show up for the outcome
measurement sessions 1 week or 6 weeks after the intervention.
In these cases, intention-to-treat and modified intention-to-treat
approaches will be employed. For cases lost to follow-up, efforts
will be made to identify the reason, for example, by phone.
Ethics Approval and Consent to Participate
This study will be carried out in accordance to the ethical
principles and national norms and standards for conducting
medical research in Iran (approval ID: IR.IUMS.REC.1398.352,
Iran National Committee for Ethics in Biomedical Research).
In addition, our informed consent form will be reviewed and
approved by the ethics committee. Prior to the commencement
of any part of the study, the principal investigator will obtain
written informed consent from all participants.
Consent for Publication
All study findings and information will be posted on
ClinicalTrials.gov (identifier NCT03990168). Although the
investigator will be free to use the study findings for educational
and scientific purposes, written consent will be obtained from
the study sponsor prior to submission of any manuscript for
publication.
Availability of Data and Materials
Information about subjects will be kept confidential and will
not be available for public access. In addition, any document,
data, voice recording, and other records will be identified by a
participant ID number, and the name of each subject will be
kept confidential. The data sets used and analyzed during the
study are available from the corresponding author upon
reasonable request.
Results
This protocol was funded in 2019 and approved by the Research
Ethics Committee of the Iran University of Medical Sciences
in June 2019. Data collection started in October 2019. As of
February 2020, we have enrolled 30 participants. We expect
that data analysis will be completed in April 2020, and the
results will be published in summer 2020.
Discussion
This is the first randomized controlled trial with follow-up
measures to explore the efficacy of tDCS combined with DAF
to improve speech fluency in adults who stutter. In this study,
the impact of the combined treatment will be evaluated by SS%
as the primary outcome measure. Treatment impact will be
examined for up to 6 weeks to exclude any temporary effects
with limited clinical value [1]. The findings of this study will
thus supply information about the efficacy of tDCS as an
adjunctive therapy for reducing SS% and its stability over a
prolonged time period.
In addition, we will obtain the SSI-4 score before and after
treatment. This score includes additional information such as
changes in the duration of stutter moments and physical
concomitants of stuttering. These parameters disrupt speech
fluency and have negative effects on communication. Reduction
in these behaviors, as expected, are relevant for the enhancement
of communication efficacy in adults who stutter [18].
Finally, we will survey the impact of stuttering on a person’s
quality of life by using the OASES questionnaire. As a
comprehensive assessment of stuttering, this questionnaire
measures the effect of stuttering on multiple life situations [19].
In summary, we anticipate that this study will show an
adjunctive effect of tDCS, when combined with DAF, on
stuttering. This should include not only a reduction in SS% but
also improved physical behavior and quality of life in adults
who stutter.
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ANOVA: analysis of variance
DAF: delayed auditory feedback
OASES: Overall Assessment of the Speaker’s Experience of Stuttering
SS%: percentage of stuttered syllables
SSI-4: Stuttering Severity Instrument-Fourth Edition
tDCS: transcranial direct current stimulation
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